Provectus Biopharmaceuticals, Inc.
PVCT
$0.0923
-$0.0046-4.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 301.31% | -48.95% | -83.18% | -47.37% | 254.63% |
| Total Receivables | -- | -- | -46.67% | -87.50% | 25.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 44.30% | -19.54% | -2.10% | -9.99% | -27.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -80.81% | -59.09% | -52.69% | -42.15% | -32.61% |
| Total Current Assets | -28.43% | -52.27% | -49.20% | -36.78% | -28.14% |
|
|
|||||
| Total Current Assets | -28.43% | -52.27% | -49.20% | -36.78% | -28.14% |
| Net Property, Plant & Equipment | -64.88% | -57.06% | -49.51% | -43.75% | -39.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -30.54% | -52.55% | -49.22% | -37.28% | -28.88% |
|
|
|||||
| Total Accounts Payable | -33.97% | -22.65% | -33.55% | -28.19% | -19.98% |
| Total Accrued Expenses | -30.67% | -47.03% | 17.87% | 13.22% | 36.80% |
| Short-term Debt | -25.67% | 41.49% | -25.89% | 23.08% | 16.04% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.37% | -11.48% | 10.92% | 23.49% | 45.47% |
| Total Finance Division Other Current Liabilities | -64.74% | -67.39% | -59.78% | -45.23% | -36.92% |
| Total Other Current Liabilities | -64.74% | -67.39% | -59.78% | -45.23% | -36.92% |
| Total Current Liabilities | -22.64% | -32.13% | -6.31% | -1.67% | 10.06% |
|
|
|||||
| Total Current Liabilities | -22.64% | -32.13% | -6.31% | -1.67% | 10.06% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -25.67% | 41.49% | -25.89% | 23.08% | 16.04% |
| Capital Leases | -- | -- | -- | -79.42% | -65.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -22.86% | -32.41% | -6.83% | -2.22% | 9.39% |
|
|
|||||
| Common Stock & APIC | 2.60% | 2.11% | 1.07% | 0.97% | 0.72% |
| Retained Earnings | -1.87% | -1.20% | -1.11% | -1.11% | -1.24% |
| Treasury Stock & Other | -0.83% | -66.30% | -68.99% | -70.70% | -68.63% |
| Total Common Equity | 21.57% | 27.91% | -2.83% | -6.39% | -21.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -37.89% | -37.78% | -41.70% | 4.07% | 2.71% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -37.89% | -37.78% | -41.70% | 4.07% | 2.71% |
|
|
|||||
| Total Common Equity | 21.57% | 27.91% | -2.83% | -6.39% | -21.85% |
| Total Preferred Equity | -37.89% | -37.78% | -41.70% | 4.07% | 2.71% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 21.39% | 27.88% | -2.96% | -6.40% | -21.91% |
|
|
|||||